<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — November 2021]]></title><description><![CDATA[<p dir="auto">tæt på ny ATH, men lukkerekord blev det da til.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400279/novo-november-2021</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 16:58:30 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400279.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 02 Nov 2021 15:00:50 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 25 Nov 2021 11:46:31 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk Says Making Significant Progress on Wegovy Supply <a href="https://www.proinvestor.com/investornyt/740842/novo-nordisk-says-making-significant-progress-on-wegovy-supply" rel="nofollow ugc">https://www.proinvestor.com/investornyt/740842/novo-nordisk-says-making-significant-progress-on-wegovy-supply</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977997</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977997</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 25 Nov 2021 11:46:31 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 19 Nov 2021 06:56:24 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Oddo: Kursmål hæves til 705 kr. fra 620 kr. <a href="https://www.proinvestor.com/investornyt/738132/novo-oddo-kursmal-haeves-til-705-kr-fra-620-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/738132/novo-oddo-kursmal-haeves-til-705-kr-fra-620-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977998</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977998</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 19 Nov 2021 06:56:24 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 18 Nov 2021 12:25:25 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Man betaler præmie - men undgår højere pris senere - <a href="https://www.proinvestor.com/investornyt/737554/novo-sydbank-man-betaler-praemie-men-undgar-hojere-pris-senere-ny" rel="nofollow ugc">https://www.proinvestor.com/investornyt/737554/novo-sydbank-man-betaler-praemie-men-undgar-hojere-pris-senere-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977994</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977994</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 18 Nov 2021 12:25:25 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 18 Nov 2021 11:13:44 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk køber det amerikanske biotekselskab Dicerna, der arbejder med rna-medicin, for 3,3 mia. dollar svarende til 22 mia. kr.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977991</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977991</guid><dc:creator><![CDATA[koden]]></dc:creator><pubDate>Thu, 18 Nov 2021 11:13:44 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 18 Nov 2021 09:28:50 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk Sales Growth Could Exceed 11% Next Year, Carnegie Says <a href="https://www.proinvestor.com/investornyt/737422/novo-nordisk-sales-growth-could-exceed-11-next-year-carnegie-says" rel="nofollow ugc">https://www.proinvestor.com/investornyt/737422/novo-nordisk-sales-growth-could-exceed-11-next-year-carnegie-says</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977995</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977995</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 18 Nov 2021 09:28:50 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 18 Nov 2021 05:14:51 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Carnegie: Kursmål hæves til 850 kr. fra 722 kr. <a href="https://www.proinvestor.com/investornyt/737379/novo-carnegie-kursmal-haeves-til-850-kr-fra-722-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/737379/novo-carnegie-kursmal-haeves-til-850-kr-fra-722-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977996</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977996</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 18 Nov 2021 05:14:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Tue, 16 Nov 2021 15:10:47 GMT]]></title><description><![CDATA[<p dir="auto">super novo dage!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977993</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977993</guid><dc:creator><![CDATA[Hamsterhjulet]]></dc:creator><pubDate>Tue, 16 Nov 2021 15:10:47 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 12 Nov 2021 10:31:31 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk Gets Label Extension Recommendation for Ozempic in Europe <a href="https://www.proinvestor.com/investornyt/734896/novo-nordisk-gets-label-extension-recommendation-for-ozempic-in-europe" rel="nofollow ugc">https://www.proinvestor.com/investornyt/734896/novo-nordisk-gets-label-extension-recommendation-for-ozempic-in-europe</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977988</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977988</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 12 Nov 2021 10:31:31 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 12 Nov 2021 09:04:49 GMT]]></title><description><![CDATA[<p dir="auto">Fantastiske aktie i 2021, skulle ha haft mere i novo end Genmab og Vestas <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977990</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977990</guid><dc:creator><![CDATA[Riis7]]></dc:creator><pubDate>Fri, 12 Nov 2021 09:04:49 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 12 Nov 2021 05:03:49 GMT]]></title><description><![CDATA[<p dir="auto">Novo/UBS: Kursmål løftes til 725 kr. fra 630 kr. - GENT <a href="https://www.proinvestor.com/investornyt/734793/novo-ubs-kursmal-loftes-til-725-kr-fra-630-kr-gent" rel="nofollow ugc">https://www.proinvestor.com/investornyt/734793/novo-ubs-kursmal-loftes-til-725-kr-fra-630-kr-gent</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977989</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977989</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 12 Nov 2021 05:03:49 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 11 Nov 2021 05:52:24 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Goldman: Hæver kursmål til 822 kr. og gentager "køb" <a href="https://www.proinvestor.com/investornyt/734096/novo-goldman-haever-kursmal-til-822-kr-og-gentager-kob" rel="nofollow ugc">https://www.proinvestor.com/investornyt/734096/novo-goldman-haever-kursmal-til-822-kr-og-gentager-kob</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977985</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977985</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 11 Nov 2021 05:52:24 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Wed, 10 Nov 2021 05:13:58 GMT]]></title><description><![CDATA[<p dir="auto">Novo/HSBC: Løfter kursmålet men ser stadig negativt potentiale <a href="https://www.proinvestor.com/investornyt/733301/novo-hsbc-lofter-kursmalet-men-ser-stadig-negativt-potentiale" rel="nofollow ugc">https://www.proinvestor.com/investornyt/733301/novo-hsbc-lofter-kursmalet-men-ser-stadig-negativt-potentiale</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977982</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977982</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 10 Nov 2021 05:13:58 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Mon, 08 Nov 2021 05:14:21 GMT]]></title><description><![CDATA[<p dir="auto">Novo/CFRA: Kursmål hæves til 675 kr. fra<br />
580 kr <a href="https://www.proinvestor.com/investornyt/731719/novo-cfra-kursmal-haeves-til-675-kr-fra-580-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/731719/novo-cfra-kursmal-haeves-til-675-kr-fra-580-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977984</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977984</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 08 Nov 2021 05:14:21 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Sat, 06 Nov 2021 01:53:24 GMT]]></title><description><![CDATA[<p dir="auto">Fantastiske NOVO…</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977979</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977979</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Sat, 06 Nov 2021 01:53:24 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 05 Nov 2021 13:21:06 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Wegovy-data peger på at man skal blive i behandlingen <a href="https://www.proinvestor.com/investornyt/730991/novo-sydbank-wegovy-data-peger-pa-at-man-skal-blive-i-behandlingen" rel="nofollow ugc">https://www.proinvestor.com/investornyt/730991/novo-sydbank-wegovy-data-peger-pa-at-man-skal-blive-i-behandlingen</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977981</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977981</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 05 Nov 2021 13:21:06 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Fri, 05 Nov 2021 12:00:27 GMT]]></title><description><![CDATA[<p dir="auto">Wegovy<img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/2122.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--tm" style="height:23px;width:auto;vertical-align:middle" title="™" alt="™" /> demonstrated significant and sustained weight loss in two-year study in adults with obesity<br />
<a href="https://www.proinvestor.com/index.php?p=debat_1&amp;postid=98349" rel="nofollow ugc">https://www.proinvestor.com/index.php?p=debat_1&amp;postid=98349</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977987</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977987</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 05 Nov 2021 12:00:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 04 Nov 2021 07:22:10 GMT]]></title><description><![CDATA[<p dir="auto">TA-VIDEO med Novo: <a href="https://www.proinvestor.com/boards/98300" rel="nofollow ugc">https://www.proinvestor.com/boards/98300</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977977</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977977</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 04 Nov 2021 07:22:10 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 04 Nov 2021 05:58:00 GMT]]></title><description><![CDATA[<p dir="auto">Verdens ledere er samlet i Glasgow og regnskabsæsonen er i fuld gang. Lyt med til afsnit 90 af #Investeringspodcasten med Hansen &amp; Larsen, hvor de ser på regnskaber fra bl.a. Ørsted, Vestas, Coloplast og Pandora og kommer ind på COP26 samt ugens gode nyheder fra Teva <a href="https://www.proinvestor.com/index.php?p=debat_1&amp;postid=98298" rel="nofollow ugc">https://www.proinvestor.com/index.php?p=debat_1&amp;postid=98298</a>.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977986</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977986</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 04 Nov 2021 05:58:00 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Thu, 04 Nov 2021 05:37:15 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Oversigt over analytikernes ændringer efter kvartalsregnskab <a href="https://www.proinvestor.com/investornyt/729624/novo-oversigt-over-analytikernes-aendringer-efter-kvartalsregnskab" rel="nofollow ugc">https://www.proinvestor.com/investornyt/729624/novo-oversigt-over-analytikernes-aendringer-efter-kvartalsregnskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977992</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977992</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 04 Nov 2021 05:37:15 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Wed, 03 Nov 2021 09:37:02 GMT]]></title><description><![CDATA[<p dir="auto">Novo/CEO: Vil kunne møde efterspørgsel efter Wegovy tidligt i 2022 -NY <a href="https://www.proinvestor.com/investornyt/728659/novo-ceo-vil-kunne-mode-eftersporgsel-efter-wegovy-tidligt-i-2022-ny" rel="nofollow ugc">https://www.proinvestor.com/investornyt/728659/novo-ceo-vil-kunne-mode-eftersporgsel-efter-wegovy-tidligt-i-2022-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977983</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977983</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 03 Nov 2021 09:37:02 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Wed, 03 Nov 2021 06:30:57 GMT]]></title><description><![CDATA[<p dir="auto">Novo OVERBLIK Q3: GLP-1 og fedmemedicin løfter salget markant <a href="https://www.proinvestor.com/investornyt/728592/novo-overblik-q3-glp-1-og-fedmemedicin-lofter-salget-markant" rel="nofollow ugc">https://www.proinvestor.com/investornyt/728592/novo-overblik-q3-glp-1-og-fedmemedicin-lofter-salget-markant</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977980</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977980</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 03 Nov 2021 06:30:57 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — November 2021 on Wed, 03 Nov 2021 06:12:30 GMT]]></title><description><![CDATA[<p dir="auto">Novo Q3: Ozempic slår forventningerne og løfter diabetesforretning <a href="https://proinvestor.com/investornyt/728585/novo-q3-ozempic-slar-forventningerne-og-lofter-diabetesforretning-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/728585/novo-q3-ozempic-slar-forventningerne-og-lofter-diabetesforretning-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7977978</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7977978</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 03 Nov 2021 06:12:30 GMT</pubDate></item></channel></rss>